Evidence for CYP2D6 Expression in Human Lung
- 8 December 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 241 (1) , 79-85
- https://doi.org/10.1006/bbrc.1997.7775
Abstract
No abstract availableKeywords
Funding Information
- Centre hospitalier régional universitaire de Lille
This publication has 20 references indexed in Scilit:
- Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolutionPharmacogenetics, 1997
- Nomenclature for human CYP2D6 allelesPharmacogenetics, 1996
- Molecular basis of polymorphic drug metabolismJournal of Molecular Medicine, 1995
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a reviewGene, 1995
- Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.Environmental Health Perspectives, 1994
- Metabolic polymorphisms in carcinogen metabolising enzymes and cancer susceptibilityBritish Medical Bulletin, 1994
- Metabolism and Elimination of Inhaled Drugs and Airborne Chemicals from the LungsBasic & Clinical Pharmacology & Toxicology, 1993
- Localization, distribution, and induction of xenobiotic-metabolizing enzymes and aryl hydrocarbon hydroxylase activity within lungPharmacology & Therapeutics, 1990
- Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene dispositionPharmacology & Therapeutics, 1990